465 related articles for article (PubMed ID: 33384552)
1. Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study.
Losurdo G; La Fortezza RF; Iannone A; Contaldo A; Barone M; Ierardi E; Di Leo A; Principi M
World J Gastroenterol; 2020 Dec; 26(47):7528-7537. PubMed ID: 33384552
[TBL] [Abstract][Full Text] [Related]
2. Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease.
Sourianarayanane A; Garg G; Smith TH; Butt MI; McCullough AJ; Shen B
J Crohns Colitis; 2013 Sep; 7(8):e279-85. PubMed ID: 23158500
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.
Long MD; Crandall WV; Leibowitz IH; Duffy L; del Rosario F; Kim SC; Integlia MJ; Berman J; Grunow J; Colletti RB; Schoen BT; Patel AS; Baron H; Israel E; Russell G; Ali S; Herfarth HH; Martin C; Kappelman MD;
Inflamm Bowel Dis; 2011 Oct; 17(10):2162-8. PubMed ID: 21910178
[TBL] [Abstract][Full Text] [Related]
4. Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease.
Flores A; Burstein E; Cipher DJ; Feagins LA
Dig Dis Sci; 2015 Aug; 60(8):2436-45. PubMed ID: 25799938
[TBL] [Abstract][Full Text] [Related]
5. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors.
Principi M; Iannone A; Losurdo G; Mangia M; Shahini E; Albano F; Rizzi SF; La Fortezza RF; Lovero R; Contaldo A; Barone M; Leandro G; Ierardi E; Di Leo A
Inflamm Bowel Dis; 2018 Jun; 24(7):1589-1596. PubMed ID: 29688336
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound Prevalence and Clinical Features of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Diseases: A Real-Life Cross-Sectional Study.
Abenavoli L; Spagnuolo R; Scarlata GGM; Scarpellini E; Boccuto L; Luzza F
Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38003983
[No Abstract] [Full Text] [Related]
8. Impact of Bariatric Surgery on the Long-term Disease Course of Inflammatory Bowel Disease.
Braga Neto MB; Gregory MH; Ramos GP; Bazerbachi F; Bruining DH; Abu Dayyeh BK; Kushnir VM; Raffals LE; Ciorba MA; Loftus EV; Deepak P
Inflamm Bowel Dis; 2020 Jun; 26(7):1089-1097. PubMed ID: 31613968
[TBL] [Abstract][Full Text] [Related]
9. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.
Zaltman C; Parra RS; Sassaki LY; Santana GO; Ferrari MLA; Miszputen SJ; Amarante HMBS; Kaiser Junior RL; Flores C; Catapani WR; Parente JML; Bafutto M; Ramos O; Gonçalves CD; Guimaraes IM; da Rocha JJR; Feitosa MR; Feres O; Saad-Hossne R; Penna FGC; Cunha PFS; Gomes TN; Nones RB; Faria MAG; Parente MPPD; Scotton AS; Caratin RF; Senra J; Chebli JM
World J Gastroenterol; 2021 Jan; 27(2):208-223. PubMed ID: 33510560
[TBL] [Abstract][Full Text] [Related]
10. Disease Activity Is Associated with Obesity in Newly Diagnosed Pediatric Patients with Ulcerative Colitis.
Kadenczki O; Dezsofi A; Cseh A; Szucs D; Vass N; Nemes E; Tarnok A; Szakos E; Guthy I; Kovacs M; Karoliny A; Czelecz J; Kiss C; Müller KE
Int J Environ Res Public Health; 2022 Dec; 19(23):. PubMed ID: 36498163
[TBL] [Abstract][Full Text] [Related]
11. A retrospective, case-control study on traditional environmental risk factors in inflammatory bowel disease in Vukovar-Srijem County, north-eastern Croatia, 2010.
Vcev A; Pezerovic D; Jovanovic Z; Nakic D; Vcev I; Majnarić L
Wien Klin Wochenschr; 2015 May; 127(9-10):345-54. PubMed ID: 25821054
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity.
Kim SK; Lee HS; Kim BJ; Park JH; Hwang SW; Yang DH; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
Can J Gastroenterol Hepatol; 2021; 2021():9981482. PubMed ID: 34381741
[TBL] [Abstract][Full Text] [Related]
13. Periodontitis prevalence and severity in inflammatory bowel disease: A case-control study.
Baima G; Muwalla M; Testa G; Mazza F; Bebars A; Perotto S; Vernero M; Massano A; Romano F; Ribaldone DG; Aimetti M
J Periodontol; 2023 Mar; 94(3):313-322. PubMed ID: 36111636
[TBL] [Abstract][Full Text] [Related]
14. Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAID.
Bacha RA; Bouhnik Y; Serrero M; Filippi J; Roblin X; Bourrier A; Bouguen G; Franchimont D; Savoye G; Buisson A; Louis E; Nancey S; Abitbol V; Reimund JM; DeWit O; Vuitton L; Mathieu N; Peyrin-Biroulet L; Gilletta C; Allez M; Viennot S; Berre CL; Laharie D; Nachury M; Amiot A;
Dig Liver Dis; 2023 Dec; 55(12):1632-1639. PubMed ID: 37246095
[TBL] [Abstract][Full Text] [Related]
15. Does inflammatory bowel disease coexist with systemic lupus erythematosus?
Shor DB; Dahan S; Comaneshter D; Cohen AD; Amital H
Autoimmun Rev; 2016 Nov; 15(11):1034-1037. PubMed ID: 27481039
[TBL] [Abstract][Full Text] [Related]
16. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
[TBL] [Abstract][Full Text] [Related]
17. Body mass index and the risk for Crohn's disease and ulcerative colitis: data from a European Prospective Cohort Study (The IBD in EPIC Study).
Chan SS; Luben R; Olsen A; Tjonneland A; Kaaks R; Teucher B; Lindgren S; Grip O; Key T; Crowe FL; Bergmann MM; Boeing H; Hallmans G; Karling P; Overvad K; Palli D; Masala G; Kennedy H; vanSchaik F; Bueno-de-Mesquita B; Oldenburg B; Khaw KT; Riboli E; Hart AR
Am J Gastroenterol; 2013 Apr; 108(4):575-82. PubMed ID: 23318483
[TBL] [Abstract][Full Text] [Related]
18. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China.
Yi F; Zhao J; Luckheeram RV; Lei Y; Wang C; Huang S; Song L; Wang W; Xia B
Virol J; 2013 Feb; 10():43. PubMed ID: 23374225
[TBL] [Abstract][Full Text] [Related]
20. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
